Baking soda study for kidney patients pulled before it started
NCT ID NCT03301558
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to see if taking sodium bicarbonate (a common antacid) could reduce the risk of harmful calcium buildup in the blood vessels of kidney transplant recipients. It planned to give participants either a low or high dose of sodium bicarbonate and measure changes in blood calcification. However, the trial was withdrawn before any patients were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sodium bicarbonate (Nephrotrans)
What this could lead to
If it had succeeded, this could have pointed toward a simple way to reduce blood vessel calcification in kidney transplant patients.
What could go wrong
The trial was withdrawn before enrolling anyone, so no data exist. Even if run, it was a small early-phase study that might not have shown a clear benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ordensklinikum Linz GmbH Elisabethinen
Linz, Upper Austria, 4020, Austria